BDMAI

Infinite Right-to-Left Scrolling Marquee
Latest Circulars

Availability of QC Manpower trained in BDMA T & T Center

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis

Workshop for Bench Chemists

Nomination for Internal Committees of BDMAI

Availability of QC Manpower trained in BDMA T & T Center

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis

Workshop for Bench Chemists

Nomination for Internal Committees of BDMAI

Govt Schemes/Notifications

S.NO. Title Document
1
National Assessment Centre (NAC) Portal for Trade and department for effective dissemination of information
2
Checklists for mandatory compliance for Cosmetics, Drugs, Medical devices to be verified by the customs officers
3
Amendment to Circular on EMI Scheme
4
DCGI Notice on Action against Illegal Manufacture and Distribution
5
Unregistered products sold through online e-commerce platform
6
Return of export cargo from international waters due to closure of the Strait of Hormuz -Sec 143AA of Customs Act
7
G.S.R 745(E)_Inclusion of additional four drugs in Schedule H1
8
S.O. 4595(E)_Prohibition of all formulations of FDC containing Chlorpheniramine Maleate and Phenylephrine HCl in children
9
Manufacturing and Marketing of Unapproved products containing Enclomiphene and its combinations
10
Public Notice Stake holder consultation on operational guidelines for Single ethics review of multi centre research in India
11
Hyderabad Industrial Lands Transformation Policy (HILTP) for strategic conversion of Industrial Land
12
Customs Circular No.10 Levy of fee for amendment or cancellation of export documents in cases of withdrawal of export consignments
13
Customs Circular No.9 of 2026 Return of export cargo from international waters due to closure of the Strait of Hormuz
14
Customs Circular No.8 of 2026 Extension of Deferred Payment of Customs Duty benefits to ‘Eligible Manufacturer Importer’ (EMI)
15
Rationalizing the requirement of green belt cover for IE/parks and Individual Industries dated 29-11-2025
16
Implementation of the Revised Schedule M Notification dated 7-11-2025
17
PLI Scheme 14th May 2025 Notification
18
Guidance document Export NOC 7.5.2025
19
Lunch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India
20
MOOWR Scheme
21
Approved Operational Guidelines (PRIP)

   22              Gazette G.S.R. 365(E)  Plastic Waste Management Rules 3rd June, 2025                                                                                                              Click Here

   23              Employment Linked Incentive Scheme Ministry of Labour & Employment                                                                                                              Click Here

   24              Public Notice on Fixation of New SION Norm   July 29,2025                                                                                                                                      Click Here

© 2021 Templately copyright all right reserved